MediPal Holdings Corporation
7459
Classifica tra le azioni
#4278
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Prezzo delle azioni
$20.40
Capitalizzazione di mercato
$3.70B
Variazione (1 giorno)
0.42%
Variazione (1 anno)
19.72%
Paese
JP
Scambia MediPal Holdings Corporation (7459)
Categoria
Healthcare
Rapporto P/E per MediPal Holdings Corporation (7459)
Rapporto P/E al October 2026 TTM: 13.55
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di MediPal Holdings Corporation, il rapporto P/E attuale (TTM) è 13.55. Alla fine del 2024, il rapporto P/E era 11.83.
Storico del rapporto P/E per MediPal Holdings Corporation da 2005 a 2026
Rapporto P/E alla fine di ogni anno
| Anno | Rapporto P/E | Cambia |
|---|---|---|
| 2026 (TTM) | 13.55 | 12.11% |
| 2025 | 12.09 | 2.20% |
| 2024 | 11.83 | 21.17% |
| 2023 | 9.76 | -32.12% |
| 2022 | 14.38 | -22.86% |
| 2021 | 18.64 | 62.38% |
| 2020 | 11.48 | -37.22% |
| 2019 | 18.28 | 29.27% |
| 2018 | 14.14 | 3.79% |
| 2017 | 13.63 | 3.92% |
| 2016 | 13.11 | -12.25% |
| 2015 | 14.94 | 6.79% |
| 2014 | 13.99 | -9.39% |
| 2013 | 15.44 | -28.55% |
| 2012 | 21.62 | -78.66% |
| 2011 | 101.31 | -23.98% |
| 2010 | 133.28 | 563.24% |
| 2009 | 20.09 | 32.62% |
| 2008 | 15.15 | -44.08% |
| 2007 | 27.10 | 41.90% |
| 2006 | 19.09 | -36.81% |
| 2005 | 30.21 | 0.00% |
Rapporto P/E per aziende simili o concorrenti
| Azienda | P/E Ratio | Differenza del P/E Ratio | Il paese |
|---|---|---|---|
| 26.02 | 91.98% |
US
|
|
| - | - |
US
|
|
| 34.08 | 151.42% |
US
|
|
| - | - |
US
|
|
| 45.62 | 236.56% |
AU
|
Come leggere un P/E ratio?
Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.
Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.
Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.